Zdrowie i gospodarka · 20/10/2022
FDA Launches Advancing Real-World Evidence Program to Enhance Prescription Drug Review Process
The US Food and Drug Administration (FDA) is launching the Advancing Real-World Evidence (RWE) Program to improve the review process for prescription drugs, as mandated by the Prescription Drug User Fee Amendments (PDUFA VII) of 2022.
Source: Federal Register — Food and Drug AdministrationOpen original release →